Ovarian Cancer and BRCA1/2 Testing: Opportunities to improve clinical care and disease prevention

Ovarian Cancer and BRCA1/2 Testing: Opportunities to improve clinical care and disease prevention

Without prevention or screening options available, ovarian cancer is the most lethal malignancy of the female reproductive tract. High grade serous ovarian cancer (HGSOC) is the most common histologic subtype, and the role of germline BRCA1/2 mutation in predisposition and prognosis is established....

Full description

Bibliographic Details
Main Authors: Katherine eKarakasis, Julia eBurnier, Valerie eBowering, Amit eOza, Stephanie eLheureux
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-05-01
Series:Frontiers in Oncology
Subjects:
Treatment
ovarian cancer
prevention
testing
BRCA1/2
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00119/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00119/full

Similar Items